医学部系列学术讲座之十一

1. 题 目：History and mission of the pharmaceutical society of Korea

报告人：Professor, Dr. In-Koo Chun

College of Pharmacy, Dongduk Women's University

时 间：2008.09.19（星期五）下午2：00-3：00

地 点：苏州大学独墅湖校区炳麟图书馆720会议室

报告人简介

Experiences

1989-1991 Visiting Scholar, College of Pharmacy, The State University of New Jersey, USA; 1987- Member, Central Drug Affairs Advising Committee, Ministry of Health and Welfare and KFDA, Korea; 1989-1994 Associate Professor, Dongduk Women's University; 1996-2000 Dean, College of Pharmacy, Dongduk Women's University; 1995-Professor, Dongduk Women's University; 2004-2006 Dean, College of Pharmacy, Dongduk Women's University, Seoul, Korea.

Academic & Society Activities

1990- Member, American Association of Pharmaceutical Scientists (AAPS), USA; 1994-1995 Editor-in-chief, Journal of Korean Pharmaceutical Sciences; 1997-Academic Secretary, PDA Korea Chapter, Korea; 1998-1999 President, The Korean-American Pharmaceutical Scientists Associations, Inc. (KAPSA), USA; 1998-2002 Vice President, The Korean Society of Pharmaceutics; 1998-2000 Trustee, The Society of Biomedical Research (SBR), USA; 1999-2004 Vice President, The Korean Society of Applied Pharmacology; 2001-2002 Secretary General, The Pharmaceutical Society of Korea; 2002-Member, Controlled Release Society, USA; 2003-2004 President, The Korean Society of Pharmaceutics; 2004-2006 Vice President, The Korean Society of Pharmaceutical Regulatoy Sciences; 2005-2006 Chairman, The Korean Association of Colleges of Pharmacy; 2005-President, The Korean Society of Applied Pharmacology; 2007-President-Elect, The Korean Society of Pharmaceutical Regulatoy Sciences; 2007-President, The Pharmaceutical Society of Korea; 2007-Deligate of FIP Council.

MAJOR RESEARCH PROJECT

Formulation and evaluation, Drug stability and stabilization, Solubilization of poorly soluble drugs, Enhanced dissolution and bioavailability, Microencapsulation, Cyclodextrin complexation, Controlled release, Solid dispersion, Transmucosal delivery of peptide and protein drugs, Trandermal drug delivery, Bioavailability and bioequivalence.

Achievement of Academia:

Patents-6, Publications-104 papers, Presentations-ca.150 abstracts, Books- 27 contributions, Research Reports-48 projects.

2. 题目：Solubilization mechanisms of nanoemulsifying solid dispersions in oral delivery

报告人：Professor Beom-Jin Lee

Department of Pharmaceutics, College of Pharmacy,

Kangwon National University, KOREA

时间：2008.09.19（星期五）下午3：00-4：00

地点：苏州大学独墅湖校区炳麟图书馆720会议室

报告人简介

Beom-Jin Lee, Ph.D. is a professor, National Research Laboratory (NRL) for Bioavailability Control, College of Pharmacy, Kangwon National University since 1993. He had served as a dean in College of Pharmacy (2005~2006). He launched numerous drug delivery products in pharmaceutical industries. He is an author/co-author of more than 70 publications, 13 domestic and PCT patents, 7 books as well as 100 domestic/120 international presentations. He has received academic advancement award (1999) and Best Manuscript Citation Award (2006) from Pharmaceutical Society of Korea (PSK) and Korean Society of Pharmaceutical Science and Technology (KSPST) in 2000. He has also received Excellent Achievement Award from the President of Kangwon National University in 2003 and 2006. He got the Lee-Sun-Kyu award in 2005 for his excellent achievement and contributions to the Korean pharmaceutical sciences. Recently, he received “Excellent Achievement in Research” was awarded by KHIDI and “Best Manuscript Award” by KOFST. His name is also listed in “Who's Who in Medicine and Healthcare (6th Eds, 2006-2007, Deluxe)” & “Who's Who in Science and Engineering (9th Ed, 2006-2007). He is currently serving as a Chief General Secretary of the PSK and an Academy-In-Chief of the KSPST. He is actively working as a President of Korean-American Pharmaceutical Scientists Associations (KAPSA) since 2006 linked with AAPS.

MAJOR RESEARCH PROJECT

1. Enhancing bioavailability of poorly soluble and poorly absorbable drugs.

2. Pharmaceutical formulations and drug delivery

3. Controlled and pulsatile release using polymeric coatings

4. Solubilization techniques and lymphatic delivery to enhance oral bioavailability

5. Chronopharmacokinetics and chronotherapeutics

PUBLICATIONS（SELECTED）

1. Modulation of microenvironmental pH and crystallinity of ionizable telmisartan using alkalizers in solid dispersions for controlled release, J. Controlled Release, 129(1), 59-65, 2008.

2. Rumen bypass and biodistribution of L-carnitine from dual-layered coated pellets in cows, in vitro and in vivo, Int. J. Pharm., 359/1-2, 87-93, 2008.

3. In vitro Metabolic Stability of Moisture-Sensitive Rabeprazole in Human Liver Microsomes and its Modulation by Pharmaceutical Excipients, Arch. Pharm. Res., 31, 406-413 (2008).

4. Effect of pharmaceutical excipients upon aqueous stability of rabeprazole sodium. Int. J. Pharm., 350(1-2) 197-204 (2008)

5. Colonic release and reduced intestinal tissue damage of coated tablets containing naproxen inclusion complex. Int. J. Pharm., 350(1-2), 205-211 (2008)

6. Determination of Highly Soluble L-carnitine in Biological Samples by Reverse Phase High Performance Liquid Chromatography with Fluorescent Derivatization. Arch. Pharm. Res., 30(8), 1041-1046 (2007).

7. Characterization of dual layered pellets for sustained release of poorly water-soluble drug, Chem Pharm Bull., 55(7), 975-979 (2007).

8. Enhanced delivery of bifidobacteria and fecal changes following the oral administration of gastric acid resistant bifidobacteria-loaded alginate poly-l-lysine microparticles in human volunteers, Drug Delivery, 14(5), 265-271 (2007).

9. Photoimages and the release characteristics of lipophilic matrix tablet containing highly water-soluble potassium citrate at high loading doses. Int. J. Pharm., 339, 19-24 (2007).

10. In vitro and in vivo comparative study of itraconazole bioavailability when formulated in highly soluble self-emulsifying system and in solid dispersion, Biopharm. Drug Disposition, 28(4), 199-207 (2007).

11. Reverse Micelle-Based Microencapsulation of Oxytetracycline Hydrochloride into Poly-d,l-Lactide-co-Glycolide Microspheres, Drug Delivery, 14(2), 95-99 (2007).